XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-based and Other Compensation
 6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-based and Other Compensation

Note 11 – Stock-based and Other Compensation

 

Omnibus Incentive Plan

 

In December 2015, Lifeway stockholders approved the 2015 Omnibus Incentive Plan, which authorized the issuance of an aggregate of 3.5 million shares to satisfy awards of stock options, stock appreciation rights, unrestricted stock, restricted stock, restricted stock units, performance shares and performance units to qualifying employees. Under the Plan, the Board or its Audit and Corporate Governance Committee approves stock awards to executive officers and certain senior executives, generally in the form of restricted stock or performance shares. The number of performance shares that participants may earn depends on the extent to which the corresponding performance goals have been achieved. Stock awards generally vest over a three-year performance or service period. At June 30, 2023, no shares remain available for award under the 2015 Omnibus Incentive Plan as it was terminated on August 31, 2022. However, any outstanding awards under the 2015 Omnibus Incentive Plan are unaffected by the termination of the 2015 Omnibus Incentive Plan or by the approval of the 2022 Omnibus Incentive Plan (the “2022 Plan”) as described below.

 

On August 31, 2022, Lifeway stockholders approved the 2022 Plan. Under the 2022 Plan, the Compensation Committee of the Board of Directors may grant awards of various types of compensation, including, nonqualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, cash-based awards and other stock-based awards. The maximum number of shares authorized to be awarded under the 2022 Plan is 3.25 million shares of common stock, which includes shares that remained available under the now terminated 2015 Omnibus Incentive Plan.

 

Awards granted under the 2022 Plan are generally subject to a minimum vesting period of at least one year. Awards may be subject to cliff-vesting or graded-vesting conditions, with graded vesting starting no earlier than one year after the grant date. The Plan Administrator may provide for shorter vesting periods in an award agreement for no more than five percent of the maximum number of shares authorized for issuance under the 2022 Plan. As of June 30, 2023, 2.77 million shares remain available to award under the 2022 Plan.

 

Stock Options

 

The following table summarizes stock option activity during the six months ended June 30, 2023:

                
   Options   Weighted
average
exercise price		   Weighted
average
remaining contractual life		   Aggregate
intrinsic value		 
Outstanding at December 31, 2022   41   $10.42    3.22   $– 
Granted   –    –    –    – 
Exercised   –    –    –    – 
Forfeited   –    –    –    – 
Outstanding at June 30, 2023   41   $10.42    2.72   $– 
Exercisable at June 30, 2023   41   $10.42    2.72   $– 

 

Restricted Stock Awards

 

A Restricted Stock Award (“RSA”) represents the right to receive one share of common stock in the future. RSAs have no exercise price. The grant date fair value of the awards is determined by the Company’s closing stock price on the grant date. Lifeway expenses RSAs over the vesting period. The following table summarizes RSA activity during the six months ended June 30, 2023.

           
    Restricted Stock Awards     Weighted Average Grant Date Fair Value  
Outstanding at December 31, 2022     164     $ 5.69  
Granted     58       6.88  
Shares issued upon vesting     –       –  
Forfeited     (5 )      6.25  
Outstanding at June 30, 2023     217     $ 5.99  
Vested and deferred at June 30, 2023     37     $ 5.60  

 

For the six months ended June 30,2023 and 2022 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $202 and $127, respectively. For the six months ended June 30,2023 and 2022 tax-related benefits of $57 and $35, respectively, were also recognized. For the three months ended June 30, 2023 and 2022 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $98 and $64, respectively. For the three months ended June 30, 2023 and 2022 tax-related benefits of $28 and $17, respectively, were also recognized. Future compensation expense related to restricted stock awards was $686 as of June 30, 2023 and will be recognized on a weighted average basis over the next 1.40 years.

 

Long-Term Incentive Plan Compensation

 

Lifeway has established long-term incentive-based compensation programs for certain senior executives and key employees pursuant to the terms of its incentive plans.

 

2020 CEO Incentive Award 

 

During the fourth quarter 2020, Lifeway awarded a long-term equity-based incentive of $750 to its Chief Executive Officer (the “2020 CEO Award”) depending on Lifeways 2020 performance levels compared to the respective targets. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. The issuance of vested equity awards is subject to approval under the Stock Purchase Agreement dated October 1, 1999. For the six months ended June 30, 2023 and 2022, $69 and $142 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. For the three months ended June 30, 2023 and 2022, $26 and $57 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of June 30, 2023, the total remaining unearned compensation was $60, of which $36 will be recognized in 2023, and $24 in 2024, respectively, subject to vesting.

 

2021 Equity Award

 

The 2021 long-term equity incentive plan compensation is based on Lifeway’s achievement of adjusted EBITDA performance versus the respective target established by the Board for 2021. Under the 2021 plan, collectively the participants earned equity-based incentive compensation of $1,069 based on Lifeway’s achievement of the respective financial target. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. For the six months ended June 30, 2023 and 2022, $128 and $278 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. For the three months ended June 30, 2023 and 2022, $44 and $112 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of June 30, 2023, the total remaining unearned compensation was $106, of which $66 will be recognized in 2023, $40 in 2024, respectively, subject to vesting.

 

2022 Equity Award

 

Under the 2022 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2022 to 2024. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 125,066 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.25 dollars per share. For the six months ended June 30, 2023 and 2022, $240 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

For the three months ended June 30, 2023 and 2022, $127 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

The 2022 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the August 31, 2022 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Award section above.

 

2023 Equity Award

 

Under the 2023 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2023 to 2025. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 115,622 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.88 dollars per share. For the six months ended June 30, 2023 and 2022, $16 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

For the three months ended June 30, 2023 and 2022, $16 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

The 2023 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the June 16, 2023 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Award section above.

 

Non-Employee Director Plan

 

On August 31, 2022, Lifeway stockholders approved the 2022 Non-Employee Director Equity and Deferred Compensation Plan (the “2022 Director Plan”), which authorizes the grant of restricted stock units (“RSUs”), which will vest on such schedule as the Company, in its sole discretion, shall determine. Each non-employee director of the Company is eligible to be a participant in the 2022 Director Plan until they no longer serve as a non-employee director. As of the date of each annual shareholder meeting, the Company may grant each director a number of RSUs for such year and set the vesting schedule for the RSUs granted. Whether and how many RSUs the Company will grant to directors in any year is subject to the sole discretion of the Company and shall in any event be subject to the 2022 Director Plan’s overall share limits. The maximum aggregate number of shares of common stock that may be issued under the 2022 Directors Plan is 500 thousand shares. As of June 30, 2023, 466 thousand shares remain available to award under the 2022 Director Plan. The aggregate fair market value of shares underlying RSU compensation that may be issued as RSU compensation to a director in any year shall not exceed $170. In addition to the grant of RSUs, the 2022 Director Plan also provides for the deferral by electing participants of all or part of their cash compensation (in 10% increments) into a deferred cash account, and they may defer all or part of their cash and/or RSU compensation (in 10% increments) into a deferred RSU account. Deferred benefits are paid in a lump sum upon the applicable director’s departure from the Board of Directors.

 

Retirement Benefits

 

Lifeway has a defined contribution plan which is available to substantially all full-time employees. Under the terms of the plan, the Company matches employee contributions under a prescribed formula. For the six months ended June 30, 2023 and 2022 total contribution expense recognized in the consolidated statements of operations was $258 and $231, respectively. For the three months ended June 30, 2023 and 2022, total contribution expense recognized in the consolidated statements of operations was $108 and $102, respectively.